Which option lists three common antiseizure medications and one key adverse effect for each?

• A. Phenytoin — gingival hyperplasia; Levetiracetam — weight gain; Valproate — hepatic toxicity
• B. Phenytoin — gingival hyperplasia; Levetiracetam — mood changes; Valproate — hepatic failure
• C. Phenytoin — osteoporosis; Levetiracetam — mood changes; Valproate — hepatotoxicity
• D. Phenytoin — gingival hyperplasia; Levetiracetam — mood/behavior changes; Valproate — hepatotoxicity and teratogenicity

Answer: (D)

The idea being tested is matching each commonly used antiseizure medication with a major adverse effect that is most characteristic and clinically important to monitor.

Phenytoin is classically linked to gingival hyperplasia, a tendency for the gums to overgrow due to effects on gingival fibroblasts and collagen turnover. Levetiracetam often presents with mood or behavior changes, such as irritability or aggression, which clinicians watch for as a notable neuropsychiatric side effect. Valproate carries a well-known risk of hepatotoxicity, and it also has significant teratogenic potential in pregnancy, making both liver injury and birth defects critical concerns.

Other pairings blur these associations: some options suggest less typical effects for levetiracetam like weight gain, or describe valproate effects in terms of hepatic failure rather than hepatotoxicity, or list osteoporosis for phenytoin, which, while possible long-term, is not as defining as gingival hyperplasia. The combination of gingival hyperplasia, mood/behavior changes, and hepatotoxicity with teratogenicity best reflects the standard, high-yield adverse-effect profiles for these three medications.